Open Orphan set to join AIM as it agrees reverse takeover of Venn Life Sciences

10:41 EDT 10 May 2019 | Proactive Investors

Open Orphan was co-founded back in 2017 by Cathal Friel, the serial Irish investor behind companies such as Amryt Pharma and Fastnet

More From BioPortfolio on "Open Orphan set to join AIM as it agrees reverse takeover of Venn Life Sciences"